Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Peringkat dalam Saham #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Harga Saham
$0.04406501
Terakhir disinkronkan: 2024-07-09
Kapitalisasi Pasar
$23.47M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan InDex Pharmaceuticals Holding AB (publ) (INDEX)

Kategori

Riwayat harga saham InDex Pharmaceuticals Holding AB (publ) (INDEX)
Harga penutupan tertinggi: $0.04 pada 2024-07-01

Harga penutupan terendah: $0.27 pada 2016-10-01
Riwayat harga saham InDex Pharmaceuticals Holding AB (publ) dari 2016 hingga 2026
Performa harga saham tahunan
Tahun Performa
2024 87.14%
2023 -26.23%
2022 -50.30%
2021 -15.30%
2020 -67.25%
2019 -14.75%
2018 30.01%
2017 -11.67%
2016 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH